Mechanisms and Functions of Chemerin in Cancer: Potential Roles in Therapeutic Intervention von Shin, Woo Jae, Zabel, Brian A, Pachynski, Russell K

Volltext

Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy von Chao, Mark P., Tang, Chad, Pachynski, Russell K., Chin, Robert, Majeti, Ravindra, Weissman, Irving L.

Volltext

Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance von Sridaran, Dhivya, Chouhan, Surbhi, Mahajan, Kiran, Renganathan, Arun, Weimholt, Cody, Bhagwat, Shambhavi, Reimers, Melissa, Kim, Eric H., Thakur, Manish K., Saeed, Muhammad A., Pachynski, Russell K., Seeliger, Markus A., Miller, W. Todd, Feng, Felix Y., Mahajan, Nupam P.

Volltext

IMC-Denoise: a content aware denoising pipeline to enhance Imaging Mass Cytometry von Lu, Peng, Oetjen, Karolyn A., Bender, Diane E., Ruzinova, Marianna B., Fisher, Daniel A. C., Shim, Kevin G., Pachynski, Russell K., Brennen, W. Nathaniel, Oh, Stephen T., Link, Daniel C., Thorek, Daniel L. J.

Volltext

Chemerin Suppresses Breast Cancer Growth by Recruiting Immune Effector Cells Into the Tumor Microenvironment von Pachynski, Russell K, Wang, Ping, Salazar, Nicole, Zheng, Yayue, Nease, Leona, Rosalez, Jesse, Leong, Weng-In, Virdi, Gurpal, Rennier, Keith, Shin, Woo Jae, Nguyen, Viet, Butcher, Eugene C, Zabel, Brian A

Volltext

The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses von Pachynski, Russell K, Zabel, Brian A, Kohrt, Holbrook E, Tejeda, Nicole M, Monnier, Justin, Swanson, Christina D, Holzer, Alison K, Gentles, Andrew J, Sperinde, Gizette V, Edalati, Abdolhossein, Hadeiba, Husein A, Alizadeh, Ash A, Butcher, Eugene C

Volltext

A “Tail” of Immunotherapy in Metastatic Prostate Cancer von Pachynski, Russell K.

Volltext

Chemerin Reactivates PTEN and Suppresses PD-L1 in Tumor Cells via Modulation of a Novel CMKLR1-mediated Signaling Cascade von Rennier, Keith, Shin, Woo Jae, Krug, Ethan, Virdi, Gurpal, Pachynski, Russell K

Volltext

IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC) von Pachynski, Russell K, Morishima, Chihiro, Szmulewitz, Russell, Harshman, Lauren, Appleman, Leonard, Monk, Paul, Bitting, Rhonda L, Kucuk, Omer, Millard, Frederick, Seigne, John D, Fling, Steven P, Maecker, Holden T, Duault, Caroline, Ramchurren, Nirasha, Hess, Bruce, D’Amico, Leonard, Lacroix, Andreanne, Kaiser, Judith C, Morre, Michel, Grégoire, Anne, Cheever, Martin, Yu, Evan Y, Fong, Lawrence

Volltext

Nivolumab plus rucaparib for metastatic castration-resistant prostate cancer: results from the phase 2 CheckMate 9KD trial von Fizazi, Karim, Retz, Margitta, Petrylak, Daniel P, Goh, Jeffrey C, Perez-Gracia, Jose, Lacombe, Louis, Zschäbitz, Stefanie, Burotto, Mauricio, Mahammedi, Hakim, Gravis, Gwenaelle, Bastos, Diogo Assed, McCune, Steven L, Vázquez Limón, Juan Carlos, Kwan, Edmond M, Castellano, Daniel, Fléchon, Aude, Saad, Fred, Grimm, Marc-Oliver, Shaffer, David R, Armstrong, Andrew J, Bhagavatheeswaran, Prabhu, Amin, Neha P, Ünsal-Kaçmaz, Keziban, Wang, Xuya, Li, Jun, Loehr, Andrea, Pachynski, Russell K

Volltext

Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial von Sharma, Padmanee, Pachynski, Russell K., Narayan, Vivek, Fléchon, Aude, Gravis, Gwenaelle, Galsky, Matthew D., Mahammedi, Hakim, Patnaik, Akash, Subudhi, Sumit K., Ciprotti, Marika, Simsek, Burcin, Saci, Abdel, Hu, Yanhua, Han, G. Celine, Fizazi, Karim

Volltext

Phase 1 Clinical Trial Evaluating the Safety and Anti-Tumor Activity of ADP-A2M10 SPEAR T-Cells in Patients With MAGE-A10+ Head and Neck, Melanoma, or Urothelial Tumors von Hong, David S, Butler, Marcus O, Pachynski, Russell K, Sullivan, Ryan, Kebriaei, Partow, Boross-Harmer, Sarah, Ghobadi, Armin, Frigault, Matthew J, Dumbrava, Ecaterina E, Sauer, Amy, Brophy, Francine, Navenot, Jean-Marc, Fayngerts, Svetlana, Wolchinsky, Zohar, Broad, Robyn, Batrakou, Dzmitry G, Wang, Ruoxi, Solis, Luisa M, Duose, Dzifa Yawa, Sanderson, Joseph P, Gerry, Andrew B, Marks, Diane, Bai, Jane, Norry, Elliot, Fracasso, Paula M

Volltext

First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma von Strauss, Julius, Deville, Jean-Laurent, Sznol, Mario, Ravaud, Alain, Maruzzo, Marco, Pachynski, Russell K, Gourdin, Theodore S, Maio, Michele, Dirix, Luc, Schlom, Jeffrey, Donahue, Renee N, Tsai, Yo-Ting, Wang, XiaoZhe, Vugmeyster, Yulia, Beier, Frank, Seebeck, Joerg, Schroeder, Andreas, Chennoufi, Sarah, Gulley, James L

Volltext

Immunotherapy and Immunotherapy Combinations in Metastatic Castration-Resistant Prostate Cancer von Bansal, Dhruv, Reimers, Melissa A, Knoche, Eric M, Pachynski, Russell K

Volltext

Chemerin modulation of tumor growth: potential clinical applications in cancer von Shin, Woo Jae, Pachynski, Russell K

Volltext

Preservation of Proteins in Human Plasma through Metal–Organic Framework Encapsulation von Wang, Yixuan, Morrissey, Jeremiah J., Gupta, Prashant, Chauhan, Pradeep, Pachynski, Russell K., Harris, Peter K., Chaudhuri, Aadel, Singamaneni, Srikanth

Volltext

Effectiveness of postoperative radiotherapy after radical cystectomy for locally advanced bladder cancer von Fischer‐Valuck, Benjamin W., Michalski, Jeff M., Mitra, Nandita, Christodouleas, John P., DeWees, Todd A., Kim, Eric, Smith, Zachary L., Andriole, Gerald L., Arora, Vivek, Bullock, Arnold, Carmona, Ruben, Figenshau, Robert S., Grubb, Robert L., Guzzo, Thomas J., Knoche, Eric M., Malkowicz, S. Bruce, Mamtani, Ronac, Pachynski, Russell K., Roth, Bruce J., Zaghloul, Mohamed S., Gay, Hiram A., Baumann, Brian C.

Volltext

Nivolumab plus docetaxel in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: results from the phase II CheckMate 9KD trial von Fizazi, Karim, González Mella, Pablo, Castellano, Daniel, Minatta, Jose N., Rezazadeh Kalebasty, Arash, Shaffer, David, Vázquez Limón, Juan C., Sánchez López, Héctor M., Armstrong, Andrew J., Horvath, Lisa, Bastos, Diogo A., Amin, Neha P., Li, Jia, Unsal-Kacmaz, Keziban, Retz, Margitta, Saad, Fred, Petrylak, Daniel P., Pachynski, Russell K.

Volltext

First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist Vopratelimab Alone and with Nivolumab: ICOS-High CD4 T-Cell Populations and Predictors of Response von Yap, Timothy A, Gainor, Justin F, Callahan, Margaret K, Falchook, Gerald S, Pachynski, Russell K, LoRusso, Patricia, Kummar, Shivaani, Gibney, Geoffrey T, Burris, Howard A, Tykodi, Scott S, Rahma, Osama E, Seiwert, Tanguy Y, Papadopoulos, Kyriakos P, Blum Murphy, Mariela, Park, Haeseong, Hanson, Amanda, Hashambhoy-Ramsay, Yasmin, McGrath, Lara, Hooper, Ellen, Xiao, Xiaoying, Cohen, Heather, Fan, Martin, Felitsky, Daniel, Hart, Courtney, McComb, Rachel, Brown, Karen, Sepahi, Ali, Jimenez, Judith, Zhang, Weidong, Baeck, Johan, Laken, Haley, Murray, Richard, Trehu, Elizabeth, Harvey, Christopher J

Volltext

A propensity analysis comparing definitive chemo-radiotherapy for muscle-invasive squamous cell carcinoma of the bladder vs. urothelial carcinoma of the bladder using the National... von Fischer-Valuck, Benjamin W., Michalski, Jeff M., Contreras, Jessika A., Brenneman, Randall, Christodouleas, John P., Abraham, Christopher D., Kim, Eric H., Arora, Vivek K., Bullock, Arnold D., Carmona, Ruben, Figenshau, Robert S., Grubb, Robert, Knoche, Eric M., Pachynski, Russell K., Picus, Joel, Roth, Bruce J., Sargos, Paul, Andriole, Gerald L., Gay, Hiram A., Baumann, Brian C.

Volltext